Carisma Therapeutics, Inc. (CARM)
OTCMKTS · Delayed Price · Currency is USD
0.0022
-0.0023 (-51.11%)
At close: Jul 29, 2026
Carisma Therapeutics Market Cap
Carisma Therapeutics has a market cap or net worth of $92.06 thousand as of July 30, 2026. Its market cap has decreased by -99.40% in one year.
Market Cap
92.06K
Enterprise Value
-1.92M
Revenue
52.63M
Ranking
n/a
PE Ratio
0.01
Stock Price
$0.00
ChartMarket Cap Chart
Since March 8, 2023, Carisma Therapeutics's market cap has decreased from 147.73M to 92.06K, a decrease of -99.94%. That is a compound annual growth rate of -88.63%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 29, 2026 | 92.06K | -94.88% |
| Dec 31, 2025 | 1.80M | -89.71% |
| Dec 31, 2024 | 17.48M | -85.21% |
| Dec 29, 2023 | 118.25M | -19.96% |
| Mar 8, 2023 | 147.73M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Actavia Life Sciences | 385.91K |
| Altamira Therapeutics | 286.35K |
| Sorrento Therapeutics | 217.49K |
| Ampio Pharmaceuticals | 207.88K |
| CNBX Pharmaceuticals | 160.58K |
| GB Sciences | 158.82K |
| Lipella Pharmaceuticals | 151.10K |
| Immunotech Laboratories | 114.99K |